In
response to the ongoing challenges patients face in paying their
out-of-pocket costs for their prescription medicines, Pfizer announced that it will immediately double the allowable income level for its
patient assistance program, so that even more patients in need could be
eligible to receive their Pfizer medicines for free. With this change,
more than 40 medicines offered for free through the program will now be
available to eligible patients earning up to 4 times the Federal Poverty
Level (FPL) adjusted for family size ($47,080 for a single person;
$97,000 for a family of four).
Through
its Pfizer RxPathways program, Pfizer offers patients, including those
with health insurance and those without, a range of individual services
to help them gain access to Pfizer medicines. In the last five years
alone (2010-2014), Pfizer has helped nearly 2.5 million uninsured and
underinsured patients get access to more than 30 million Pfizer
prescriptions, making it the most comprehensive program of its kind.
Pfizer RxPathways is a joint program of Pfizer Inc. and the Pfizer Patient Assistance Foundation™.
Pfizer
RxPathways is part of Pfizer’s corporate social investment strategy
that focuses on leveraging the full range of the company’s resources –
people, skills, expertise and funding – to broaden access to medicines
and strengthen health care delivery for underserved people around the
world.
